Navigation Links
New UV-C-Reflective Wall Coating Dramatically Reduces Disinfection Times for TRU-D Device
Date:5/10/2013

CHAPEL HILL, N.C., May 10, 2013 /PRNewswire/ -- A recent study published in Infection Control and Hospital Epidemiology ( William A. Rutala , Ph.D., MPH, et al., 2013) confirms the ability of a new UV-C-reflective wall coating to dramatically reduce the time necessary to decontaminate a room using the UV-C-emitting device TRU-D SmartUVC™.

TRU-D, the signature product of Memphis-based Lumalier, is the only portable UV disinfection system on the market that precisely measures reflected UV-C emissions with Sensor360™ to automatically calculate the pathogen-lethal UV dose required for proper and consistent disinfection of health care environments. Thanks to the device's patented technology and intuitive nature, TRU-D "sees" the reflective properties in the wall coating and automatically adjusts the cycle time to the appropriate dose of UV-C emission necessary to disinfect the room of harmful pathogens.

The study, which utilized a TRU-D device in a patient hospital room at University of North Carolina Clinical Translational Research Center in Chapel Hill, tested the difference in cycle time necessary to achieve microbial termination on 10 inoculated templates placed at various locations throughout the room before and after the room was coated with the new UVC360™ Reflective Wall Coating from Lumacept. Rutala and his team concluded the following time reductions for decontamination: methicillin-resistant Staphylococcus aureus, from 25 minutes 13 seconds to five minutes three seconds, and Clostridium difficile spores, from 43 minutes 42 seconds to nine minutes 24 seconds.

"Because of TRU-D's Sensor360 technology, it is the only UV disinfection device that is able to react to the improved reflectivity of the wall coating, allowing for the precise measurement of necessary UV dose to be adjusted and therefore reduced" said Chuck Dunn , president of Lumalier, maker of TRU-D. "This is a new and highly valuable component for hospitals using TRU-D, as it allows a faster turnaround of patient areas without loss of confidence in complete terminal disinfection."

It has been previously reported that standard approaches to environmental cleaning have proven inadequate with studies showing that 50 percent or more of hospital surfaces go untouched during terminal room disinfection. It is also well-documented that these pathogens, and others such as vancomycin-resistant Enterococcus and carbapenem-resistant Enterobacteriaceae, can persist on environmental surfaces for days, weeks and even months. This can lead to the transmission of these hardy pathogens from one patient to another via the contaminated hands of health care personnel or environmental surfaces in patient areas. Previously published data has supported the use of TRU-D as a complement to a hospital's comprehensive cleaning and disinfection program for effective environmental disinfection in order to reduce these health care-associated infections.

According to the study, the wall coating is similar in appearance to a common interior latex paint and is applied as such (by brush, roller or spray), but it is formulated with inorganic oxides, polymer binders and functional additives with chemical structures that are minimally absorbent of UV-C, and therefore produce a much higher UV reflectivity (65 percent) versus standard paint, which has a low 3 to 7 percent UV reflectivity.

UVC360™ Reflective Wall Coating from Lumacept will be featured in booth 1923 at the 40th annual APIC Conference in Fort Lauderdale.  For information about TRU-D SmartUVC, UVC360 Reflective Wall Coating from Lumacept, and all third-party studies published on the device, visit www.TRU-D.com.

For more information, contact:
Kerri Guyton
Obsidian Public Relations
Phone: 662-422-8012
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com


'/>"/>
SOURCE Lumalier
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
2. The Treatment Landscape for Thyroid Carcinoma Will Change Dramatically Through 2021
3. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
4. Ochsner Health System Dramatically Improves Efficiency Using Hyland Softwares OnBase Solution
5. CVS Caremark Industry-Leading Generic Dispensing Rate Reduces Client Traditional Drug Spend by 3.6 Percent for 2012
6. Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
7. Pre-Sutured Tendon From LifeNet Health Increases Surgeon Efficiency, Reduces Operation Room Time
8. Hands-On Treatment Improves Chronic Low Back Pain, Reduces Medication Use
9. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
10. Improved Device Programming Reduces Inappropriate Therapy and Risk of Death for Implantable Defibrillator Patients
11. Southern Home Medical Once Again Reduces The Companys Issued And Outstanding Preferred Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
Breaking Medicine News(10 mins):